Search for a doctor

Ayse Tuba Kendi, M.D.

  1. Radiologist
Request an Appointment

Publications

  1. Muniz M, Sartor O, Orme JJ, Koch RM, Rosenow HR, Mahmoud AM, Andrews JR, Kase AM, Riaz IB, Belge Bilgin G, Thorpe MP, Kendi AT, Johnson GB, Ravi P, Kwon ED, Childs DS. Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [(177)Lu]Lu-PSMA-617. J Nucl Med. 2024 Dec 3; 65 (12):1932-1938 Epub 2024 Dec 03
    View PubMed
  2. Calais J, Morris MJ, Kendi AT, Kalebasty AR, Tutrone R, Anderson MJ, Sartor O. Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy. J Nucl Med. 2024 Nov 1; 65 (11):1666-1671 Epub 2024 Nov 01
    View PubMed
  3. Belge Bilgin G, Bilgin C, Orscelik A, Burkett BJ, Thorpe MP, Johnson DR, Johnson GB, Kallmes DF, Sartor O, Kendi AT. Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysis. Ann Nucl Med. 2024 Nov; 38 (11):865-876 Epub 2024 Sept 17
    View PubMed
  4. Bogsrud TV, Engelsen O, Lu TTT, Stensvold A, Johnson DR, Burkett BJ, Kendi AT, Pandey MK, Sundset R, Durski JM. All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [(177)Lu]Lu-PSMA-radioligand will be successful. EJNMMI Res. 2024 Oct 15; 14 (1):95
    View PubMed
  5. Belge Bilgin G, Burkett BJ, Bilgin C, Orme JJ, Childs DS, Rincon MM, Abdelrazek AS, Johnson DR, Johnson GB, Kwon ED, Sartor O, Kendi AT. Neurologic Symptoms After (177)Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience. J Nucl Med. 2024 Sep 3; 65 (9):1402-1408 Epub 2024 Sept 03
    View PubMed
  6. Kuo PH, Morris MJ, Hesterman J, Kendi AT, Rahbar K, Wei XX, Fang B, Adra N, Garje R, Michalski JM, Chi K, de Bono J, Fizazi K, Krause B, Sartor O, Tagawa ST, Ghebremariam S, Brackman M, Wong CC, Catafau AM, Benson T, Armstrong AJ, Herrmann K. Quantitative (68)Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following (177)Lu-PSMA-617 (VISION Trial). Radiology. 2024 Aug; 312 (2):e233460
    View PubMed
  7. Song C, Jung D, Kendi AT, Rho JK, Kim EJ, Horn I, Curran GL, Ghattamaneni S, Shim JY, Kang PS, Kang D, Thakkar JB, Dewan S, Lowe VJ, Lee SB. Metformin Prevents Tumor Cell Growth and Invasion of Human Hormone Receptor-Positive Breast Cancer (HR+ BC) Cells via FOXA1 Inhibition. Int J Mol Sci. 2024 Jul 8; 25 (13) Epub 2024 July 08
    View PubMed
  8. Chauhan A, Chan K, Halfdanarson TR, Bellizzi AM, Rindi G, O'Toole D, Ge PS, Jain D, Dasari A, Anaya DA, Bergsland E, Mittra E, Wei AC, Hope TA, Kendi AT, Thomas SM, Flem S, Brierley J, Asare EA, Washington K, Shi C. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2024 Jul-Aug; 74 (4):359-367 Epub 2024 Apr 29
    View PubMed
  9. Ahmed ME, Lee MS, Mahmoud AM, Joshi VB, Gopalakrishna A, Bole R, Haloi R, Kendi AT, Bold MS, Bryce AH, Karnes RJ, Kwon ED, Childs DS, Andrews JR. Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024 Jun; 27 (2):334-338 Epub 2023 Nov 07
    View PubMed
  10. Mahmoud AM, Ahmed ME, Kendi AT, Thorpe M, Johnson GB, Riaz IB, Orme JJ, Kwon ED, Andrews JR, Childs DS. Low PSA radiographic disease progression on C11-choline PET. BJUI Compass. 2024 Mar; 5 (2):319-324 Epub 2023 Oct 25
    View PubMed
  11. Mahmoud AM, Childs DS, Ahmed ME, Tuba Kendi A, Johnson GB, Orme JJ, Stish BJ, Phillips RM, Park SS, Davis BJ, Andrews JR, Kwon ED. Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis. Prostate. 2024 Feb; 84 (3):237-244 Epub 2023 Oct 29
    View PubMed
  12. Belge Bilgin G, Bilgin C, Childs DS, Orme JJ, Burkett BJ, Packard AT, Johnson DR, Thorpe MP, Riaz IB, Halfdanarson TR, Johnson GB, Sartor O, Kendi AT. Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer (177)Lu-PSMA-617 therapy. Front Oncol. 2024; 14:1386718 Epub 2024 July 12
    View PubMed
  13. Belge Bilgin G, Navin PJ, Johnson DR, Sartor O, Kendi AT. Acute pancreatitis and biliary obstruction from metastatic lymph node compression during [(177)Lu] Lu-PSMA-617 therapy: a case report. Front Oncol. 2024; 14:1442293 Epub 2024 Oct 07
    View PubMed
  14. Rochon PJ, Reghunathan A, Kapoor BS, Kalva SP, Fidelman N, Majdalany BS, Abujudeh H, Caplin DM, Eldrup-Jorgensen J, Farsad K, Guimaraes MS, Gupta A, Higgins M, Kendi AT, Khilnani NM, Patel PJ, Dill KE, Hohenwalter EJ, Expert Panels on Interventional Radiology and Vascular Imaging. ACR Appropriateness Criteria(R) Lower Extremity Chronic Venous Disease. J Am Coll Radiol. 2023 Nov; 20 (11S):S481-S500
    View PubMed
  15. Halfdanarson TR, Mallak N, Paulson S, Chandrasekharan C, Natwa M, Kendi AT, Kennecke HF. Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy. Cancers (Basel). 2023 Oct 2; 15 (19) Epub 2023 Oct 02
    View PubMed
  16. Kendi AT. Prostate cancer: Advances in genetic testing and clinical implications Uro. 2023.
  17. Pantel AR, Eiber M, Beyder DD, Kendi AT, Laforest R, Rauscher I, Silberstein EB, Thorpe MP. SNMMI Procedure Standard/EANM Practice Guideline for Palliative Nuclear Medicine Therapies of Bone Metastases. J Nucl Med Technol. 2023 Sep; 51 (3):176-187 Epub 2023 June 14
    View PubMed
  18. Kuo PH, Yoo DC, Avery R, Seltzer M, Calais J, Nagarajah J, Weber WA, Fendler WP, Hofman MS, Krause BJ, Brackman M, Kpamegan E, Ghebremariam S, Benson T, Catafau AM, Kendi AT. A VISION Substudy of Reader Agreement on (68)Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for (177)Lu-PSMA-617 Radioligand Therapy. J Nucl Med. 2023 Aug; 64 (8):1259-1265 Epub 2023 May 25
    View PubMed
  19. Jang A, Kendi AT, Johnson GB, Halfdanarson TR, Sartor O. Targeted Alpha-Particle Therapy: A Review of Current Trials. Int J Mol Sci. 2023 Jul 19; 24(14).
    View PubMed
  20. Burkett BJ, Bartlett DJ, McGarrah PW, Lewis AR, Johnson DR, Berberoglu K, Pandey MK, Packard AT, Halfdanarson TR, Hruska CB, Johnson GB, Kendi AT. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements. Radiol Imaging Cancer. 2023 Jul; 5 (4):e220157
    View PubMed
  21. Ensign SF, Agarwal M, Klanderman M, Badawy M, Halfdanarson TR, Johnson DR, Sonbol MB, Kendi AT. Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions. Nucl Med Commun. 2023 Jul 1; 44 (7):663-670 Epub 2023 May 08
    View PubMed
  22. Fizazi K, Herrmann K, Krause BJ, Rahbar K, Chi KN, Morris MJ, Sartor O, Tagawa ST, Kendi AT, Vogelzang N, Calais J, Nagarajah J, Wei XX, Koshkin VS, Beauregard JM, Chang B, Ghouse R, DeSilvio M, Messmann RA, de Bono J. Health-related quality of life and pain outcomes with [(177)Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2023 Jun; 24 (6):597-610
    View PubMed
  23. Badawy M, Johnson G, Wee C, Halfdanarson TR, Abdelrazek A, Packard A, Jain M, Thorpe M, Kendi. Intestinal obstruction in patients receiving peptide receptor radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: potential predictors and association with overall survival. J Nucl Med. 2023; 64(Supplement 1):439.
  24. Ashara Y, Lee K, Halfdanarson TR, Wigle D, Kendi, Leventakos K. Sensitivity of 68-Ga DOTATATE scan as a diagnostic characteristic for primary tumor and nodal metastasis of pulmonary neuroendocrine tumor after surgical resection J Nucl Med. 2023; 64(Supplement 1):275.
  25. Gococo-Benore DA, Kuhlman J, Parent EE, Sharma A, Accurso J, Yang M, Kendi AT, Johnson G, Sonbol MB, Hobday T, Halfdanarson TR, Starr J. Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden. J Nucl Med. 2023 Jun; 64 (6):880-884 Epub 2023 Apr 20
    View PubMed
  26. Song C, Kendi AT, Shim JY, Jung D, Kang PS, Lowe VJ, Lee S. ER-/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor. Breast Cancer. 2023 May; 30 (3):436-452 Epub 2023 Mar 01
    View PubMed
  27. Calais J, Eulau SM, Gardner L, Hauke RJ, Kendi AT, Shore ND, Zhao S. Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer. Cancer Treat Rev. 2023 Apr; 115:102524 Epub 2023 Feb 11
    View PubMed
  28. Lehner K, Kendi AT. High volume mCRPC is associated with decreased cancer specific survival in patients on second-generation hormone therapy in the post docetaxel setting ASCO. 2023.
  29. Jang A, Kendi AT, Sartor O. Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials. Ther Adv Med Oncol. 2023; 15:17588359231157632 Epub 2023 Mar 04
    View PubMed
  30. Huls SJ, Burkett B, Ehman E, Lowe VJ, Subramaniam RM, Kendi AT. Clinical practice in prostate PET imaging. Ther Adv Med Oncol. 2023; 15:17588359231213618 Epub 2023 Nov 22
    View PubMed
  31. Shim JY, Chung JO, Jung D, Kang PS, Park SY, Kendi AT, Lowe VJ, Lee S. Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic beta cells. PLoS One. 2023; 18 (5):e0281496 Epub 2023 May 03
    View PubMed
  32. Alamiri J, Britton CJ, Ahmed ME, Andrews JR, Higa JL, Dundar A, Karnes RJ, Kwon E, Lowe VJ, Kendi AT, Bold MS, Pagliaro LC. Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis. Prostate. 2022 Dec; 82(16):1483-1490. Epub 2022 Sep 11.
    View PubMed
  33. Andrews JR, Ahmed ME, Sharma V, Britton C, Stish B, Phillips R, Kendi AT, Joshi VB, Sood A, Tollefson MK, Boorjian SA, Karnes RJ, Kwon ED. Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer. J Urol. 2022 Dec; 208(6):1240-1249. Epub 2022 Nov 09.
    View PubMed
  34. Liu AJ, Kosiorek HE, Ueberroth BE, Jaeger E, Ledet E, Kendi AT, Tzou K, Quevedo F, Choo R, Moore CN, Ho TH, Singh P, Keole SR, Wong WW, Sartor O, Bryce AH. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. Prostate. 2022 Sep; 82(12):1202-1209. Epub 2022 Jun 02.
    View PubMed
  35. Badawy M, Johnson G, Jain M, Kendi AT, Johnson DR, Porter A, Yang M, Sonbol MB. Intracranial neuroendocrine tumour simulating meningioma for several years: an overview of diagnosis and treatment. BJR Case Rep. 2022 Sep; 8(3):20210222. Epub 2022 Jan 27.
    View PubMed
  36. Fizazi TK, Vaishampayan N, Morris M, Krause B, Vogelzang N, Kendi A, Nordquist L, Nagarajah J, Beer T, El-Haddad G, Sartor O. 177Lu]Lu-PSMA-617 dans le cancer de la prostate metastatique positif au PSMA et resistant a la castration: analyses des sous-groupes de traitement anterieurs et concomitants de l'essai vision J FPurol. 2022.
  37. Kuo PH, Yoo DC, Avery R, Seltzer M, Calais J, Nagarajah J, Weber WA, Fendler WP, Hofman MS, Krause BJ, Catagau A, Kpamegan E, Brackman M, Kendi AT. Reader agreement of [68Ga]Ga-PSMA-11 PET/CT scan interpretation to determine patient eligibility for [177Lu]Lu-PSMA-617 radioligand therapy: a VISION sub-study JNMMI. 2022.
  38. Gococo-Benore DA, Parent E, Sharma A, Accurso J, Yang M, Kendi AT, Sonbol B, Halfdanarson TR, Starr JS. Hepatotoxicity from peptide receptor radionuclide therapy (prrt) in neuroendocrine tumors (nets) patients with very high liver tumor burden. Pancreas. 2022; 51(3):E47.
  39. Song C, Kendi AT, Lowe VJ, Lee S. The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast Cancer. Anticancer Res. 2022 Feb; 42(2):681-695.
    View PubMed
  40. Elwazir M, Krause ML, Bois JP, Christopoulos G, Kendi AT, Cooper JLT, Jouni H, AbouEzzeddine OF, Chareonthaitawee P, Abdelshafee M, Amin S. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience. J Card Fail. 2022 Feb; 28(2):247-258. Epub 2021 Jul 25.
    View PubMed
  41. Abdelrazek A, Mahmoud AA, Joshi VB, Habeeb M, Ahmed ME, Ghoniem K, Delgado A, Khater N, Kwon E, Kendi AT. Recent advances in prostate cancer (PCa) diagnostics Uro. 2022; 2:109-121.
  42. Jimbo M, Andrews JR, Ahmed ME, Dundar A, Karnes RJ, Bryce AH, Kendi AT, Kwon ED, Lowe VJ, Bold MS. Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy. Prostate. 2022 Jan; 82(1):41-48. Epub 2021 Oct 11.
    View PubMed
  43. Fizazi K, Flippot R. Hermann K, Krause BJ, Rahbar K, Chi KN, Morris MJ, Sartor O, Tagawa ST, Kendi AT, Vogelzang N, Calais J, Nagarajah J, Wei XX, Koshkin VS, Beauregard JM, Chang B, DeSilvio M, Messmann RA, deBono J. Resultats de qualite de vie liee a la sante, douleur et tolerance de l'etude de phase 3 VISION due 177Lu-PSMA-617 chez des patients atteints d'un CPRCm Medicine Nucleatre. 2022; 46:51.
  44. Panda A, Sharma A, Dundar A, Packard A, Aase L, Kotsenas A, Kendi AT. Twitter Use by Academic Nuclear Medicine Programs: Pilot Content Analysis Study. JMIR Form Res. 2021 Nov 08; 5(11):e24448.
    View PubMed
  45. Sandhya Manohar, Panagiotis Kompotiatis, Thorvardur R Halfdanarson, Timothy J Hobday, Matthew Thorpe, Geoffrey B Johnson, Ayse Tuba Kendi, Nelson Leung.. 177Lu-dotatate use in chronic kidney disease patients: A single center experience Journal of Onco-Nephrology. 2021; 5(3):162-171.
  46. Wee CE, Dundar A, Eiring RA, Badawy M, Hobday TJ, Kendi AT, Packard AT, Halfdanarson TR. Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy. J Nucl Med 2021 Sep 1; 62 (9):1320 Epub 2021 Mar 19
    View PubMed
  47. Ahmed ME, Joshi VB, Badawy M, Pagliaro LC, Karnes RJ, Lowe V, Thorpe MP, Kwon ED, Kendi AT. Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OS. Clin Genitourin Cancer. 2021 Jun; 19 (3):223-229 Epub 2021 Jan 07
    View PubMed
  48. Young JR, Graham RP, Venkatesh SK, Kendi AT. (18)F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature. Abdom Radiol (NY). 2021 Jun; 46 (6):2604-2609 Epub 2021 Feb 08
    View PubMed
  49. Liu AJ, Ueberroth BE, McGarrah PW, Buckner Petty SA, Kendi AT, Starr J, Hobday TJ, Halfdanarson TR, Sonbol MB. Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors. Oncologist. 2021 May; 26 (5):383-388 Epub 2021 Feb 08
    View PubMed
  50. Sanli Y, Simsek DH, Sanli O, Subramaniam RM, Kendi AT. (177)Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer. Biomedicines. 2021 Apr 15; 9 (4)
    View PubMed
  51. Panda A, Hintermeister HA, Hunt CH, Kendi AT. Whole-body 18-F-FDG-PET in patients with leptomeningeal disease and correlation with MRI. Nucl Med Commun. 2021 Feb 1; 42 (2):205-215
    View PubMed
  52. Panda A, McCarthy MR, Murray JA, Sharain RF, Shi M, Kendi AT. Incidentally Detected Celiac Disease with Splenomegaly on 18F FDG PET/CT: A Potential Lymphoma Mimic Asia Oceania Journal of Nuclear Medicine and Biology. 2020.
  53. Osman K, Maselli D, Kendi AT, Larson M. Bouveret's syndrome and cholecystogastric fistula: a case-report and review of the literature. Clin J Gastroenterol. 2020 Aug; 13 (4):527-531 Epub 2020 Mar 30
    View PubMed
  54. Zurkiya O, Ganguli S, Kalva SP, Chung JH, Shah LM, Majdalany BS, Bykowski J, Carter BW, Chandra A, Collins JD, Gunn AJ, Kendi AT, Khaja Ms, Liebeskind DS, Maldonado F, Obara P, Sutphin PD, Tong BC, Vijay K, Corey AS, Kanne JP, Dill KE. Expert Panels on Vascular Imaging, Thoracic Imaging and Neurological Imaging J Am Coll Radiol. 2020; 17(5S):S323.
  55. Lee RK, Burns J, Ajam AA, Broder JS, Chakraborty S, Chong ST, Kendi AT, Ledbetter LN, Liebeskind DS, Pannell JS, Pollock JM, Rosenow JM, Shaines MD, Shih RY, Slavin K, Utukuri PS, Corey AS. Expert Panels on Neurological Imaging J Am Coll Radiol. 2020; 17(5S):S293. Epub 2022 Jan 05.
  56. Kendi AT, Mailman JA, Naraev BG, Mercer DJ, Underwood JK, Halfdanarson TR. Patient Travel Concerns After Treatment with (177)Lu-DOTATATE. J Nucl Med. 2020 Apr; 61 (4):496-497 Epub 2020 Mar 13
    View PubMed
  57. Jimbo M, Ahmed ME, Andrews JR, Alom M, Dundar A, Karnes RJ, Bryce AH, Kendi AT, Kwon ED, Bold MS. Prognostic role of [11C] choline PET-CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy Urology. 2020.
  58. Starr JS, Sonbol MB, Hobday TJ, Sharma A, Kendi AT, Halfdanarson TR. Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights. Onco Targets Ther. 2020; 13:3545-3555 Epub 2020 Apr 28
    View PubMed
  59. Friedman SN, Mahmood M, Geske JR, Sohail MR, Johnson GB, Stulak JM, Kendi AT. Positron emission tomography objective parameters for assessment of left ventricular assist device infection using (18)F-FDG PET/CT. Am J Nucl Med Mol Imaging. 2020; 10 (6):301-311 Epub 2020 Dec 15
    View PubMed
  60. Obara P, McCool J, Kalva SP, Majdalany BS, Collins JD, Eldrup-Jorgensen J, Ganguli S, Gunn AJ, Kendi AT, Khaja MS, Sutphin PD, Vijay K, Dill KE. Expert Panel on vascular Imaging J AM Coll Radiol. 2019; 16(11S):S340.
  61. Dundar A, Bold MS, Agac B, Kendi AT, Friedman SN. Stroke detection with 3 different PET tracers. Radiol Case Rep. 2019 Nov; 14 (11):1447-1451 Epub 2019 Oct 01
    View PubMed
  62. Tian S, Ferris MJ, Switchenko JM, Magliocca KR, Cassidy RJ, Jhaveri J, Aiken AH, Baugnon KL, Hudgins PA, Kendi ATK, Patel MR, Saba NF, Curran WJ, Beitler JJ. Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma. Head Neck. 2019 Sep; 41 (9):3056-3063 Epub 2019 May 02
    View PubMed
  63. Kendi AT, Halfdanarson TR, Packard A, Dundar A, Subramaniam RM. Therapy With (177)Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors. AJR Am J Roentgenol. 2019 Aug; 213 (2):309-317 Epub 2019 Apr 30
    View PubMed
  64. Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, Chareonthaitawee P, Friedman PA, Sohail MR. Role of (18)F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019 Jun; 26 (3):958-970 Epub 2017 Sept 14
    View PubMed
  65. Mahmood M, Kendi AT, Ajmal S, Farid S, O'Horo JC, Chareonthaitawee P, Baddour LM, Sohail MR. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2019 Jun; 26 (3):922-935 Epub 2017 Oct 30
    View PubMed
  66. Naraev BG, Ramirez RA, Kendi AT, Halfdanarson TR. Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids. Clin Lung Cancer. 2019 May; 20 (3):e376-e392 Epub 2019 Mar 01
    View PubMed
  67. Luttrull MD, Boulter DJ, Kirsch CFE, Aulino JM, Broder JS, Chakraborty S, Choudhri AF, Ducruet AF, Kendi AT, Lee RK, Liebeskind DS, Mack W, Moritani T, Roca RP, Shah LM, Sharma A, Shih RY, Symko SC, Bykowski J, Expert Panel on Neurological Imaging:. ACR Appropriateness Criteria((R)) Acute Mental Status Change, Delirium, and New Onset Psychosis. J Am Coll Radiol. 2019 May; 16 (5S):S26-S37
    View PubMed
  68. Oien M, Johnson GB, Geske JR, Sohail MR, Kendi AT, Stulak JM, Mahmood M. Infiltrative cardiomyopathies and infection imaging J Nucl Med Molec Imaging. 2019; (Suppl 1).
  69. Friedman S, Sohail Mr, Mahmood M, Kendi AT. Assessment of LVAD infections with PET/CT parameters J Nucl Med Molec Imaging. 2019; (Suppl 1).
  70. Broski SM, Young JR, Kendi AT, Subramaniam RM. Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis. PET Clin. 2019 Jan; 14 (1):103-120 Epub 2018 Oct 24
    View PubMed
  71. Shah LM, Jennings JW, Kirsch CFE, Hohenwalter EJ, Beaman FD, Cassidy RC, Johnson MM, Kendi AT, Lo SS, Reitman C, Sahgal A, Scheidt MJ, Schramm K, Wessell DE, Kransdorf MJ, Lorenz JM, Bykowski J, Expert Panels on Neurological Imaging, Interventional Radiology, and Musculoskeletal Imaging:. ACR Appropriateness Criteria((R)) Management of Vertebral Compression Fractures. J Am Coll Radiol. 2018 Nov; 15 (11S):S347-S364
    View PubMed
  72. Sanli Y, Garg I, Kandathil A, Kendi T, Zanetti MJB, Kuyumcu S, Subramaniam RM. Neuroendocrine Tumor Diagnosis and Management: (68)Ga-DOTATATE PET/CT. AJR Am J Roentgenol. 2018 Aug; 211 (2):267-277 Epub 2018 July 05
    View PubMed
  73. Garg I, Zanetti Baladron M, Kendi AT. Nested stromal epithelial tumor of the liver with recurrent extra-hepatic metastasis Indian J Nuclear Medicine.2017;
  74. Expert Panel on Neurologic Imaging, Kessler MM, Moussa M, Bykowski J, Kirsch CFE, Aulino JM, Berger KL, Choudri AF, Fife TD, Germano IM, Kendi AT, Luttrull MD, Nunez D Jr, Shah LM, Sharma A, Shetty VS, Symko SC, Cornelius RS. ACR Appropriateness Criteria Tinnitus J Am Coll Radiol.2017;14:(11S):S584.
  75. Garg I, Baladron Zanetti MJ, Kendi AT. Bone Scan in Evaluation of Bone Viability in Severe Frostbite of the Hand. Indian J Nucl Med. 2017 Oct-Dec; 32 (4):367-368
    View PubMed
  76. Garg I, Baladron Zanetti MJ, Yasir S, Goenka AH, Kendi AT. PET/CT in an 8-Year-Old Girl With Epstein-Barr Virus-Associated Smooth Muscle Tumor. Clin Nucl Med. 2017 Oct; 42 (10):770-772
    View PubMed
  77. Bykowski J, Aulino JM, Berger KL, Cassidy RC, Choudhri AF, Kendi AT, Kirsch CFE, Luttrull MD, Sharma A, Shetty VS, Than K, Winfree CJ, Cornelius RS, Expert Panel on Neurologic Imaging:. ACR Appropriateness Criteria((R)) Plexopathy. J Am Coll Radiol. 2017 May; 14 (5S):S225-S233
    View PubMed
  78. Morris C, Barron BJ, Kendi AT. Ruptured mycotic aneurysm of common carotid artery ACR.2017;
  79. Kendi AT, Moncayo VM, Nye JA, Galt JR, Halkar R, Schuster DM. Radionuclide therapies in molecular imaging and prevision medicine PET Clin.2017;12:(1):93-103.
    View PubMed
  80. Kendi AT, Brandon D, Switchenko J, Wadsworth JT, El-Deiry MW, Saba NF, Schuster DM, Subramaniam RM. Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study. Am J Nucl Med Mol Imaging. 2017; 7 (4):174-180 Epub 2017 Sept 01
    View PubMed
  81. Edalat F, Camacho JC, Kokabi N, Karagulle Kendi AT, Galt J, Kim K. Standardized added metabolic activity (SAM) predicts survival after intra-arterial resin-based yttrium-90 (Y90) radioembolization therapy in unresectable chemorefractory metastatic colorectal cancer to the liver Clin Nucl Med.2016;41:(2):e76.
    View PubMed
  82. Shetty VS, Reis MN, Aulino JM, Berger KL, Broder J, Choudhri AF, Kendi AT, et al. ACR Apporpriateness criteria, head trauma J Am Coll Radiol.2016;13:(6):668.
    View PubMed
  83. Karagulle Kendi AT, Singh SR, Park D, Barron B. A case of granulomatous slack skin cutaneous T cell lymphoma: PET/CT imaging findings Auntminnie.com.2016;
  84. Kendi AT, Corey A, Magliocca KR, Galt JR, Zhang C, Chen Z, Higgins K, Beitler JJ, Wadsworth JT, El-Deiry MW, Schuster DM, Saba NF, Hudgins PA. Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration? Eur J Radiol.2016;85:(2):319.
    View PubMed
  85. Kendi AT, Magliocca KR, Corey A, Galt JR, Switchenko J, Wadsworth JT, El-Deiry MW, Schuster DM, Saba NF, Hudgins PA. Is there a role of PET/CT parameters to characterize benign, malignant, and metastatic parotid tumors AJR.2016;207:(3):635.
    View PubMed
  86. Roth CJ, Angevine PD, Aulino JM, Berger KL, Choudhri AF, Fries IB, Holly LT, Kendi AT, Kessler MM, Kirsch CF, Luttrull MD, Mechtler LL, O'Toole JE, Sharma A, Shetty VS, West OC, Cornelius RS, Bykowski J. ACR appropriateness criteria Myelopathy J Am Coll Radiol.2016;13:(1):38.
    View PubMed
  87. Kendi AT, Mudalegundi S, Switchenko J, Lee D, Halkar R, Chen AY. Assessment of the role of different imaging modalities with emphasis on FDG PET/CT in the management of well differentiated thyroid cancer (WDTC) Thyroid Disorders Ther.2016;5:1.
  88. Karagulle Kendi AT, Barron BJ, Bonta D, Halkar RK, Rathore B, Schuster DM. Another "great mimicker": FDG PET/CT findings of sarcoid like reaction BJR/Case Rep.2015;1:No.1:20150060.
  89. Plaxton NA, Brandon DC, Corey AS, Harrison CE, Karagulle Kendi AT, Halkar RK, Barron BJ. Characteristics and limitations of FDG PET/CT for imaging of squamous cell carcinoma of the head and neck: A comprehensive review of anatomy, metastatic pathways, and image findings Am J Roentgenol.2015;205:(5):W519.
    View PubMed
  90. Kendi AT, Magliocca K, Corey A, Nickleach DC, Galt J, Higgins K, Beitler JJ, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM. Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status? Clin Nucl Med.2015;40:(3):e196.
    View PubMed
  91. Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma: is visual analysis of PET and contrast enhanced CT better than the numbers? Eur J Radiol.2015;84:(6):1171.
    View PubMed
  92. Karagulle Kendi AT, Singh SR, Park D, Barron B. A case of granulomatous slack skin cutaneous T cell lymphoma: PET/CT imaging findings BJR/Case Rep.2015;1:20150052.
  93. Bachanova V, Cao Q, Ustun C, Kendi AT, Froelich J, Lazaryan A, Burns LJ. Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT Bone Marrow Transplant.2015;50:(1):142.
    View PubMed
  94. Singh C, Kendi AT, Manivel JC, Pambuccian SE. Renal angiomyoadenomatous tumor Ann Diagn Pathol.2012;16:(6):470.
    View PubMed
  95. Kendi AT, Khariwala SS, Zhang J, Idiyatullin DS, Corum CA, Michaeli S, Pambuccian SE, Garwood M, Yueh B. Transformation in mandibular imaging with sweep imaging with fourier transform magnetic resonance imaging Arch Otolaryngol Head Neck Surg .2011;137:(9):916.
    View PubMed
  96. Allen TL, Kendi AT, Mitiek MO, Maddaus MA. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer Semin Thorac Cardiovasc Surg.2011;23:(1):43.
    View PubMed
  97. Kendi AT, Brace JR. Vertebral artery duplication and aneurysms: 64 slice multidetector CT findings Br J Radiol.2009;82:(983):e216.
    View PubMed
  98. Nagar VA, McKinney AM, Karagulle AT, Truwit CL. Reperfusion phenomenon masking acute and subacute infarcts at dynamic perfusion CT: confirmation by fusion of CT and diffusion weighted MR images Am J Roentgenol.2009;193:1629.
    View PubMed
  99. McKinney AM, Kieffer SA, Paylor RT, SantaCruz K, Kendi A, Lucato L. Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion weighted and FLAIR imaging Am J Roentgenol.2009;193:(1):192.
    View PubMed
  100. McKinney AM, Palmer CS, Truwit CL, Karagulle A, Teksam M. Detection of aneurysms by 64-section multidetector CT angiography in patients acutely suspected of having an intracranial aneurysm and comparison with digital subtraction and 3D rotational angiography Am J Neuroradiol.2008;29:(3):594.
    View PubMed
  101. Karagulle Kendi AT, Krenzel C, Ott FW, Brace JR, Norberg SK, Kieffer SA. Poststreptococcal dystonia with bilateral striatal enlargement: MR imaging and spectroscopic findings Am J Neuroradiol.2008;29:(7):1276.
    View PubMed
  102. Kendi M, Kendi AT, Lehericy S, Ducros M, Lim KO, Ugurbil K, Schulz SC, White T. Structural and diffusion tnesor imaging of the fornix in childhood-and-adolescent-onset schizophrenia J Am Acad Child Adolesc Psychiatry.2008;47:(7):826.
    View PubMed
  103. McKinney AM, Thompson LR, Truwit CL, Velders S, Karagulle A, Kiragu A. Unilateral hypoxic-ischemic injury in young children from abusive head trauma, lacking craniocervical vascular dissection or cord injury Pediatr Radiol.2008;38:(2):164.
    View PubMed
  104. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P. Altered diffusion in the frontal lobe in Parkinson disease Am J Neuroradiol.2008;29:(3):501.
    View PubMed
  105. Kendi AT, McKinney AM, Clark HB, Kieffer SA. A pediatric case of low grade lymphomatoid geranulomatosis presenting with a cerebellar mass Am J Neuroradiol.2007;28:1803.
  106. Kolbe AB, McKinney AM, Kendi AT, Misselt D. Aspergillus meningitis and discitis from low-back procedures in an immunocompetent patient. Acta Radiol. 2007 Jul; 48: (6)687-9.
    View PubMed
  107. Bademci G, Kendi T, Agalar F. Persistent metopic suture can mimic the skull fractures in the emergency setting? Neurocirugia (Astur).2007;18:238.
  108. White T, Kendi AT, Lehericy S, Kendi M, et al. Disruption of hippocampal connectivity in children and adolescents schizophrenia - a vosel based diffusion tensor imaging study Schizophr Res.2007;90:(1-3):302.
    View PubMed
  109. Kendi AT, Gudemez E. Sonographic evaluation of scapholunate ligament: Value of tissue harmonic imaging J Clin Ultrasound.2006;34:109.
  110. Arikan OK, Koc C, Kendi T, Muluk NB, Ekici A. CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis Acta Otolaryngol.2006;126:37.
  111. Kendi T, Batislam E, Basar MM, Yilmaz E, Altinok D, Basar H. Magnetic resonance imaging (MRI) in penile metastases of extragenitourinary cancers Int Urol Nephrol.2006;38:105.
  112. Arikan OK, Tan FU, Kendi T, Koc C. Use of botulinum toxin type A for treatment of masseteric muscle hypertrophy J Otolaryngol.2006;35:40.
  113. Keles I I, Aydin G, Kendi TK, Orkun S. Multifocal osteoarticular tuberculosis: a case report Rheumatol Int.2005;25:307.
  114. Karagulle Kendi AT, Kendi M, Agildere M, Yilmaz S. MR imaging findings of a large epidermal cyst Eur J Radiol Extra.2005;53:7.
  115. Keles I, Karagulle Kendi AT, Aydin G, Zog SG, Orkun S. Diagnostic precision of ultrasonography in patients with carpal tunnel syndrome Am J Phys Med Rehabil.2005;84:(6):443.
    View PubMed
  116. Kendi TK, Arikan OK, Koc C. Volume of componentns of labyrinth: Magnetic Resonance Imaging Oto Neurotol.2005;26:778.
  117. Kendi AT, Tan FU, Kendi M, Erdal HH, Tellioglu S. Magnetic resonance spectroscopy of thalamus in essential tremor patients J Neuroimaging.2005;15:362.
  118. Erden GA, Karagulle Kendi AT, Erden I. MRCP evaluatioan of biliary system following vagotomy and gastric surgery J Clin Imaging.2005;29:42.
  119. Kendi T, Bademci G. Post-operative spinal ultrasonography findings in spinal dysraphia Diagn Inter Radiol.2005;11:142.
  120. Uslu M, Ozsar B, Kendi T, Kara S, Tekdemir I, Atik OS. The use of computed tomography to determine femoral component size: a study of cadaver femora Bull Hosp Jt Dis.2005;63:49.
  121. Saglik Y, Kendi TK, Yildiz HY, Erakar A, Gungor A, Erekul S. Clavicular osteoma associated with bronchial osteomas Skeletal Radiology.2004;33:204.
  122. Karagulle Kendi T, Agildere M, Erdal HH. Cochlear nerve deficiency-labyrinthine dysplasia in a child with congenital sensorineural hearing loss Eur J Radiol Extra.2004;49:7.
  123. Karagulle Kendi T, Rodrigez C, Kemal G, Karadeniz Bilgili Y and Huvaj S. Medial orbital wall protrusion: computed tomography findings Eur J Radiol Extra.2004;51:69.
  124. Karagulle Kendi T, Caglar S, Huvaj S, Bademci G, Kendi M, Alparslan S. Suprasellar germ cell tumor with subarachnoid seeding: MRI and MR spectroscopy findings Clinical Imaging.2004;28:404.
  125. Akarsu C, Tan FU, Kendi T. Color Doppler imaging in optic neuritis with multiple sclerosis Graefes Arch Clin Exp Ophthalmol.2004;242:(12)990.
  126. Kendi TK, Erakar A, Oktay O, Yildiz HY, Saglik Y. Accessory soleus muscle J Am Podiatr Med Assoc.2004;94:(6)587.
  127. Kendi AT, Tan FU, Kendi M, Yilmaz S, Huvaj S, Tellioglu S. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis Neuroradiology.2004;13:
  128. Kendi TK, Arikan OK, Koc C. Magnetic resonance imaging of chochlear modiolus: determination of mid-modiolar area and modiolar volume J Laryngol Octol.2004;118:(7)496.
  129. Karadeniz Bilgili YM, Unal B, Kendi T, Simsir I, Erdal H, Huvaj S, Kara S, Bademci G. The effect of aging on the apparent diffusion coefficient of normal appearing white and gray matter Tani Girisim Radyol.2004;10:(1)4.
  130. Kendi TK, erakar A, Yildiz HY, Saglik Y, Erekul S. Intraosseous malignant peripheral nerve sheath tumor with local recurrence, lung metastases and death Skeletal Radiol.2004;33:(4)223.
  131. Karagulle Kendi T, Erakar A, Saglik Y, Yildiz HY, Erekul S. Desmoplastic fibroma of bone: a case report J Clin Imaging.2003;27:200.
  132. Kendi T, Arikan OK, Koc C. MR spectroscopy in a cervical abscess Neuroradiology.2003;45:631.
  133. Karagulle Kendi AT, Altinok D, Kara S, Erdal HH. Forearm muscle herniation: MR imaging findings Skeletal Radiology.2003;32:364.
  134. Kendi AT, Kara S, Altinok D, Keskil S. Sinonasal ossifying fibroma with fluid-fluid levels on MR images AJNR.2003;24:(8)1639.
  135. Karagulle T, Erden A, Erden I, Zilelioglu G. Nasolacrimal system: evaluation with gadolinium-enhanced MR dacryocystography with three-dimensional fast spoiled gradient recalled technique Eur Radiol.2002;12:2343.
  136. Karadag D, Karagulle AT, Erden I, Erden A. Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MR imaging. Eur J Radiol.2002;44:(1):16.
    View PubMed
  137. Sancak T, Karagulle AT, Bilgic S, Sanlidilek U. Stent dilatation of a closed mesocaval shunt in a patient with Budd-Chiari syndrome Cardiovascular and Interventional Radiology.2002;25:(4):332.
    View PubMed
  138. Karadag D, Karagulle AT, Erden A, Erden I. MR imaging of a ruptured intraspinal dermoid tumor with fat droplets in the central spinal canal Australas Radiol.2002;46:(4):444.
    View PubMed
  139. Tukel S, Karagulle AT. Mammographic density changes in post menopausal women undergoing hormone replacement therapy: differences between different treatments, a preliminary study Gynecology, Obstetrics and Reproductive Medicine.2002;8:42.
  140. Karagulle AT, Erden A, Karadag D, Erden I. Sneddon's syndrome: MR imaging findings Eur Radiol.2002;12:(1):144.
    View PubMed
  141. Karagulle AT, Karadag D, Erden A, Erden I. MR findings AUTF dergisi.2001;
  142. Karagulle AT, Atasoy C, Erden I. Intraventricular oligodendroglioma AUTF dergisi.2001;
  143. Sancak T, Bilgic S, Karagulle AT, Sanlidilek U. Stent Application in a patient with chronic mesenteric ischemia Damar Cerrahisi Dergisi.2001;10:90.
  144. Karadag D, Karagulle AT, Erden A, Colpan E, Erden I, Caglar S, Erekul S. Post traumatic intradiplic epidermoid cyst. A Case Report. J Neurosurg Sci.2001;45:(4)224.
  145. Erden A, Fitoz S, Karagulle T, Tukel S, Akyar S. Radiological findings in the diagnosis of gentiourinary candidiasis Pediatr Radiol.2000;30:875.
  146. Fitoz S, Erden A, Karagulle T, Akyar S. Interruption of gallbladder wall with pericholecystic fluid: a CT finding of perforation. Emergency Radiology.2000;7:253.
  147. Fitoz S, Erden A, karagulle T, Akyar S. Congenital cystic adenomatoid malformation of lungs Tanisal ve Girismisel Radyoloji.2000;6:98.
PST-20258446